Grupo 29: Farmacología y Fisiopatología Vascular

Código de grupo: 7.29
Tipo de grupo: Consolidado 
Descripción del grupo
: Farmacología y fisiopatología vascular
Jefe de Grupo: Francisco Pérez Vizcaíno

Integrantes del grupo
Investigadores y personal de apoyo
BARON ARGOS LOURDES
BARREIRA BARBA BIANCA Other
CARRIÓN MARCHANTE REBECA
COGOLLUDO TORRALBA ÁNGEL Established Researcher
DA COSTA ADAO RUI MIGUEL Recognised Researcher
GIMENO LONGAS MARÍA JOSÉ Recognised Researcher
MORALES CANO DANIEL Recognised Researcher
MORENO GUTIERREZ LAURA Established Researcher
OLIVENCIA PLAZA MIGUEL ÁNGEL First Stage Researcher
PÉREZ VIZCAÍNO FRANCISCO Leading Researcher
SANCHO GONZÁLEZ MARÍA Recognised Researcher
VILLEGAS ESGUEVILLAS MARTA First Stage Researcher
Líneas de investigación
Axis 1. Pulmonary Hypertension

L1: Pulmonary vascular dysfunction in pulmonary hypertension (PH).

L2: Role of vitamin D and the microbiota in pulmonary hypertension (PH).

L3: Role of TASK1 and Kv7 potassium channels in pulmonary hypertension.

L4: Role of mutations in the KCNA5 gene in pulmonary hypertension patients.

L5: Liver-lung axis. How liver exosomes from healthy and cirrhotic animals influence the lung.

Axis 2. Erectile dysfunction

L1: Role of vitamin D and microbiota in erectile dysfunction.

Axis 3. Acute lung damage

L1: Acute Respiratory Distress Syndrome (ARDS).

L2: Bronchodysplasia of the lung (BDP).

First decile publications 1 7,0
First quartile publications 3 22,2
Second quartile publications 1 6,0
Third quartile publications 0 0,0
Total publications (including those without IF) 4 28,2

 

 

 

 

 

 

 

 

 

 

SUBIR ↑